{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:52Z","timestamp":1783032412522,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T00:00:00Z","timestamp":1307059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00266-011-9757-1","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T06:03:57Z","timestamp":1307081037000},"page":"174-179","source":"Crossref","is-referenced-by-count":11,"title":["Polyacrylamide Gel for Facial Wasting Rehabilitation: How Many Milliliters per Session?"],"prefix":"10.1007","volume":"36","author":[{"given":"R.","family":"Rauso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gherardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Parlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tartaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,3]]},"reference":[{"issue":"23","key":"9757_CR1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJM199512073332303","volume":"333","author":"SA Danner","year":"1995","unstructured":"Danner SA, Carr A, Leonard JM, Lehman LM, Gudiol F, Gonzales J, Raventos A, Rubio R, Bouza E, Pintado V et al (1995) A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med 333(23):1528\u20131533","journal-title":"N Engl J Med"},{"issue":"11","key":"9757_CR2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","volume":"337","author":"SM Hammer","year":"1997","unstructured":"Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 337(11):725\u2013733","journal-title":"N Engl J Med"},{"key":"9757_CR3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.280.1.78","volume":"280","author":"CCJ Carpenter","year":"1998","unstructured":"Carpenter CCJ, Fischl MA, Hammer SM et al (1998) Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA 280:78\u201386","journal-title":"JAMA"},{"key":"9757_CR4","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1742-1241.2007.01385.x","volume":"61","author":"L Waters","year":"2007","unstructured":"Waters L, Nelson M (2007) Long-term complications of antiretroviral therapy: lipoatrophy. Int J Clin Pract 61:999\u20131014","journal-title":"Int J Clin Pract"},{"key":"9757_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","volume":"39","author":"KA Lichtenstein","year":"2005","unstructured":"Lichtenstein KA (2005) Redefining lipodystrophy syndrome: risks and impact on clinical decision making. J Acquir Immune Defic Syndr 39:395\u2013400","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"9757_CR6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12(7):F51\u2013F58","journal-title":"AIDS"},{"key":"9757_CR7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ et al (2001) Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15:1389\u20131398","journal-title":"AIDS"},{"key":"9757_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","volume":"31","author":"E Bernasconi","year":"2002","unstructured":"Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A et al (2002) Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort study. J Acquir Immune Defic Syndr 31:50\u201355","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9757_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","volume":"4","author":"J Miller","year":"2003","unstructured":"Miller J, Carr A, Emery S, Law M, Mallal S, Baker D et al (2003) HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med 4:293\u2013301","journal-title":"HIV Med"},{"key":"9757_CR10","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353:2093\u20132099","journal-title":"Lancet"},{"key":"9757_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","volume":"13","author":"C Gervasoni","year":"1999","unstructured":"Gervasoni C, Ridolfo AL, Trifiro G, Santambrogio S, Norbiato G, Musicco M et al (1999) Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 13:465\u2013471","journal-title":"AIDS"},{"issue":"Suppl","key":"9757_CR12","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.asj.2005.08.002","volume":"26","author":"A Strand","year":"2006","unstructured":"Strand A, Wolters M (2006) HIV-related lipodystrophy and facial lipoatrophy: the role of Restylane SubQ in reversing facial wasting. Aesthet Surg J 26(Suppl):S35\u2013S40","journal-title":"Aesthet Surg J"},{"issue":"18","key":"9757_CR13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","volume":"15","author":"S Duran","year":"2001","unstructured":"Duran S, Sav\u00e8s M, Spire B, Cailleton V, Sobel A, Carrieri P, Salmon D, Moatti JP, Leport C (2001) Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 15(18):2441\u20132444","journal-title":"AIDS"},{"key":"9757_CR14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.PRS.0000128427.54445.63","volume":"114","author":"JM Serra-Renom","year":"2004","unstructured":"Serra-Renom JM, Fontdevila J (2004) Treatment of facial atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection. Plast Reconstr Surg 114:551\u2013555","journal-title":"Plast Reconstr Surg"},{"key":"9757_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bjps.2007.10.031","volume":"61","author":"L Nelson","year":"2008","unstructured":"Nelson L, Stewart KJ (2008) Experience in the treatment of HIV-associated lipodystrophy. J Plast Reconstr Aesthet Surg 61:366\u2013371","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"9757_CR16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","volume":"23","author":"LP Sturm","year":"2009","unstructured":"Sturm LP, Cooter RD, Mutimer KL, Graham JC, Maddern GJ (2009) A systematic review of permanent and semipermanent dermal fillers for HIV-associated facial lipoatrophy. AIDS Patient Care STDS 23:699\u2013714","journal-title":"AIDS Patient Care STDS"},{"key":"9757_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1293.2008.00667.x","volume":"10","author":"D Carey","year":"2009","unstructured":"Carey D, Baker D, Petoumenos K, Chuah J, Rogers GD, Watson J, Cooper DA, Emery S, Carr A (2009) Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up. HIV Med 10:163\u2013172","journal-title":"HIV Med"},{"issue":"6","key":"9757_CR18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00266-008-9189-8","volume":"32","author":"RB Karim","year":"2008","unstructured":"Karim RB, de Lint CA, van Galen SR, van Rozelaar L, Nieuwkerk PT, Askarizadeh E, Hage JJ (2008) Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients. Aesthetic Plast Surg 32(6):873\u2013878","journal-title":"Aesthetic Plast Surg"},{"issue":"1","key":"9757_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.PSN.0000313951.20647.12","volume":"28","author":"S Dinman","year":"2008","unstructured":"Dinman S (2008) Sculptra use in HIV-associated lipodystrophy. Plast Surg Nurs 28(1):53\u201354","journal-title":"Plast Surg Nurs"},{"issue":"4","key":"9757_CR20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/SCS.0b013e31811eda9c","volume":"19","author":"J H\u00f6nig","year":"2008","unstructured":"H\u00f6nig J (2008) Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients. J Craniofac Surg 19(4):1085\u20131088","journal-title":"J Craniofac Surg"},{"issue":"9","key":"9757_CR21","first-page":"884","volume":"7","author":"N Reytan","year":"2008","unstructured":"Reytan N, Rzany B (2008) Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment. J Drugs Dermatol 7(9):884\u2013886","journal-title":"J Drugs Dermatol"},{"key":"9757_CR22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2105\/AJPH.91.7.1060","volume":"91","author":"JM Karon","year":"2001","unstructured":"Karon JM, Fleming PL, Steketee RW, DeCock KM (2001) HIV in the United States at the turn of the century. Am J Public Health 91:1060","journal-title":"Am J Public Health"},{"key":"9757_CR23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.prs.0000298108.46379.15","volume":"121","author":"G Santis De","year":"2008","unstructured":"De Santis G, Jacob V, Baccarani A, Pedone A, Pinelli M, Spaggiari A, Guaraldi G (2008) Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: a 2\u00a0year clinical experience. Plast Reconstr Surg 121:644\u2013653","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"9757_CR24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/apc.2006.20.829","volume":"20","author":"E Negredo","year":"2006","unstructured":"Negredo E, Higueras C, Adell X, Martinez JC, Martinez E, Puig J et al (2006) Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS 20(12):829\u2013837","journal-title":"AIDS Patient Care STDS"},{"key":"9757_CR25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/aid.2008.0230","volume":"25","author":"E Negredo","year":"2009","unstructured":"Negredo E, Puig J, Aldea D, Medina M, Estany C et al (2009) Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy. AIDS Res Hum Retrovir 25:451\u2013455","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"9757_CR26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.asj.2008.06.005","volume":"28","author":"LC Kates","year":"2008","unstructured":"Kates LC, Fitzgerald R (2008) Poly-l-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review. Aesthet Surg J 28(4):397\u2013403","journal-title":"Aesthet Surg J"},{"key":"9757_CR27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/01.PRS.0000133425.22598.D0","volume":"114","author":"E Zarini","year":"2004","unstructured":"Zarini E, Supino R, Pratesi G, Laccabue D, Tortoreto M, Scanziani E et al (2004) Biocompatibility and tissue interactions of a new filler material for medical use. Plast Reconstr Surg 114:934\u2013942","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"9757_CR28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.prs.0000254824.13065.3b","volume":"119","author":"G Bello","year":"2007","unstructured":"Bello G, Jackson IT, Keskin M, Kelly C, Dajani K, Studinger R, Kim EM et al (2007) The use of polyacrylamide gel in soft tissue augmentation: an experimental assessment. Plast Reconstr Surg 119(4):1326\u20131336","journal-title":"Plast Reconstr Surg"},{"key":"9757_CR29","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.PRS.0000056873.87165.5A","volume":"111","author":"LC Christensen","year":"2003","unstructured":"Christensen LC, Breiting VB, Aasted A, Jorgensen A, Kebuladze I (2003) Long term effects of polyacrylamide hydrogel (PAAG, Interfall\/Contura SA) in human breast tissue. Plast Reconstr Surg 111:1883","journal-title":"Plast Reconstr Surg"},{"key":"9757_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00266-004-0113-6","volume":"29","author":"LC Christensen","year":"2005","unstructured":"Christensen LC, Breiting V, Janssen M et al (2005) Adverse reaction to injectable soft tissue permanent fillers. Aesthetic Plast Surg 29:34","journal-title":"Aesthetic Plast Surg"},{"key":"9757_CR31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1089\/apc.2007.0029","volume":"21","author":"G Orlando","year":"2007","unstructured":"Orlando G, Guaraldi G, De Fazio D et al (2007) Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomised study. AIDS Patient Care STDS 21:833\u2013841","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"9757_CR32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/09540120802511851","volume":"21","author":"J Hornberger","year":"2009","unstructured":"Hornberger J, Rajagopalan R, Shewade A, Loutfy MR (2009) Cost consequences of HIV-associated lipoatrophy. AIDS Care 21(5):664\u2013671","journal-title":"AIDS Care"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-011-9757-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00266-011-9757-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-011-9757-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:02:02Z","timestamp":1558717322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00266-011-9757-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9757"],"URL":"https:\/\/doi.org\/10.1007\/s00266-011-9757-1","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,3]]}}}